NMR Structure and Dynamics of Monomeric Neutrophil-activating Peptide 2

Overview

Journal Biochem J

Specialty Biochemistry

Date 1999 Mar 3

PMID 10051427

Citations 10

Authors

H Young

V Roongta

T J Daly

K H Mayo

Affiliations

Soon will be listed here.

Abstract

Neutrophil-activating peptide 2 (NAP-2), which demonstrates a range of proinflammatory activities, is a 72-residue protein belonging to the alpha-chemokine family. Although NAP-2, like other alpha-chemokines, is known to self-associate into dimers and tetramers, it has been shown that the monomeric form is physiologically active. Here we investigate the solution structure of monomeric NAP-2 by multi-dimensional 1H-NMR and 15N-NMR spectroscopy and computational modelling. The NAP-2 monomer consists of an amphipathic, triple-stranded, anti-parallel beta-sheet on which is folded a C-terminal alpha-helix and an aperiodic N-terminal segment. The backbone fold is essentially the same as that found in other alpha-chemokines. 15N T1, T2 and nuclear Overhauser effects (NOEs) have been measured for backbone NH groups and used in a model free approach to calculate order parameters and conformational exchange terms that map out motions of the backbone. N-terminal residues 1 to 17 and the C-terminus are relatively highly flexible, whereas the beta-sheet domain forms the most motionally restricted part of the fold. Conformational exchange occurring on the millisecond time scale is noted at the top of the C-terminal helix and at proximal residues from beta-strands 1 and 2 and the connecting loop. Dissociation to the monomeric state is apparently responsible for increased internal mobility in NAP-2 compared with dimeric and tetrameric states in other alpha-chemokines.

Citing Articles

Heterologous Interactions with Galectins and Chemokines and Their Functional Consequences.

Mayo K Int J Mol Sci. 2023; 24(18).

PMID: 37762385 PMC: 10531749. DOI: 10.3390/ijms241814083.

Heterodimers Are an Integral Component of Chemokine Signaling Repertoire.

Kaffashi K, Dreau D, Nesmelova I Int J Mol Sci. 2023; 24(14).

PMID: 37511398 PMC: 10380872. DOI: 10.3390/ijms241411639.

Chemokines from a Structural Perspective.

Miller M, Mayo K Int J Mol Sci. 2017; 18(10).

PMID: 28974038 PMC: 5666770. DOI: 10.3390/ijms18102088.

Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin.

Brown A, Sepuru K, Rajarathnam K Int J Mol Sci. 2017; 18(3).

PMID: 28245630 PMC: 5372524. DOI: 10.3390/ijms18030508.

Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™.

Dykstra A, Sweeney M, Leary J Biomolecules. 2014; 3(4):905-22.

PMID: 24970196 PMC: 4030970. DOI: 10.3390/biom3040905.

References

Fesik S, Zuiderweg E . Heteronuclear three-dimensional NMR spectroscopy of isotopically labelled biological macromolecules. Q Rev Biophys. 1990; 23(2):97-131. DOI: 10.1017/s0033583500005515. View

Crump M, Gong J, Loetscher P, Rajarathnam K, Amara A, Virelizier J . Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 1998; 16(23):6996-7007. PMC: 1170303. DOI: 10.1093/emboj/16.23.6996. View

Clore G, Bax A, Wingfield P, Gronenborn A . Identification and localization of bound internal water in the solution structure of interleukin 1 beta by heteronuclear three-dimensional 1H rotating-frame Overhauser 15N-1H multiple quantum coherence NMR spectroscopy. Biochemistry. 1990; 29(24):5671-6. DOI: 10.1021/bi00476a004. View

Baldwin E, Weber I, St Charles R, Xuan J, Appella E, Yamada M . Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci U S A. 1991; 88(2):502-6. PMC: 50839. DOI: 10.1073/pnas.88.2.502. View

Mayo K . Low-affinity platelet factor 4 1H NMR derived aggregate equilibria indicate a physiologic preference for monomers over dimers and tetramers. Biochemistry. 1991; 30(4):925-34. DOI: 10.1021/bi00218a007. View

Moser B, Schumacher C, Von Tscharner V, Clark-Lewis I, Baggiolini M . Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem. 1991; 266(16):10666-71. View

Holt J, Yan Z, Lu W, Stewart G, Niewiarowski S . Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein. Proc Soc Exp Biol Med. 1992; 199(2):171-7. DOI: 10.3181/00379727-199-43343. View

Barbato G, Ikura M, Kay L, Pastor R, Bax A . Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry. 1992; 31(23):5269-78. DOI: 10.1021/bi00138a005. View

Myers J, GRAY G, Peters D, Grimaila R, Hunt A, Maione T . Expression and purification of active recombinant platelet factor 4 from a cleavable fusion protein. Protein Expr Purif. 1991; 2(2-3):136-43. DOI: 10.1016/1046-5928(91)90062-n. View

10.

Schumacher C, Clark-Lewis I, Baggiolini M, Moser B . High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A. 1992; 89(21):10542-6. PMC: 50375. DOI: 10.1073/pnas.89.21.10542. View

11.

Yang Y, Barker S, Chen M, Mayo K . Effect of low molecular weight aliphatic alcohols and related compounds on platelet factor 4 subunit association. J Biol Chem. 1993; 268(13):9223-9. View

12.

Deuel T, Keim P, Farmer M, Heinrikson R . Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A. 1977; 74(6):2256-8. PMC: 432148. DOI: 10.1073/pnas.74.6.2256. View

13.

Begg G, Pepper D, Chesterman C, Morgan F . Complete covalent structure of human beta-thromboglobulin. Biochemistry. 1978; 17(9):1739-44. DOI: 10.1021/bi00602a024. View

14.

Castor C, Miller J, Walz D . Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc Natl Acad Sci U S A. 1983; 80(3):765-9. PMC: 393460. DOI: 10.1073/pnas.80.3.765. View

15.

Wuthrich K, Billeter M, Braun W . Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J Mol Biol. 1983; 169(4):949-61. DOI: 10.1016/s0022-2836(83)80144-2. View

16.

Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M . Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1):76-85. DOI: 10.1016/0003-2697(85)90442-7. View

17.

Holt J, Harris M, Holt A, Lange E, Henschen A, Niewiarowski S . Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. Biochemistry. 1986; 25(8):1988-96. DOI: 10.1021/bi00356a023. View

18.

Brunger A, Clore G, Gronenborn A, Karplus M . Three-dimensional structure of proteins determined by molecular dynamics with interproton distance restraints: application to crambin. Proc Natl Acad Sci U S A. 1986; 83(11):3801-5. PMC: 323611. DOI: 10.1073/pnas.83.11.3801. View

19.

Clore G, Brunger A, Karplus M, Gronenborn A . Application of molecular dynamics with interproton distance restraints to three-dimensional protein structure determination. A model study of crambin. J Mol Biol. 1986; 191(3):523-51. DOI: 10.1016/0022-2836(86)90146-4. View

20.

Schmid J, Weissmann C . Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes. J Immunol. 1987; 139(1):250-6. View